BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 11251037)

  • 1. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
    Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
    Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
    Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
    Chiu A; Chan LM; Fan ST
    Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: clinical experience with Prometheus.
    Rifai K; Manns MP
    Ther Apher Dial; 2006 Apr; 10(2):132-7. PubMed ID: 16684214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients.
    Pugliese F; Novelli G; Poli L; Levi Sandri GB; Di Folco G; Ferretti S; Morabito V; Ruberto F; Berloco PB
    Transplant Proc; 2008; 40(6):1925-8. PubMed ID: 18675091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver support therapy with molecular adsorbents recirculating system in liver failure: a summary of 252 cases from 14 centers in China.
    Wang MM; Chen SJ; Ye QF; Yang YJ; Chen SB; Zhou XM; Guo LM; Zhang YX; Ding XQ; Hu XB; Luo HT; Liu YH; Wang WY
    Chin Med J (Engl); 2008 Nov; 121(21):2197-201. PubMed ID: 19080184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
    Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
    Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
    Marangoni R
    G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of an adult with Amanita phalloides-induced fulminant liver failure with molecular adsorbent recirculating system (MARS).
    Lionte C; Sorodoc L; Simionescu V
    Rom J Gastroenterol; 2005 Sep; 14(3):267-71. PubMed ID: 16200238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin regeneration in liver support-comparison of different methods.
    Mitzner S; Klammt S; Stange J; Schmidt R
    Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure].
    Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
    Khuroo MS; Khuroo MS; Farahat KL
    Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.
    Wittebole X; Hantson P
    Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
    Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
    Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of Mars therapy with and without transplantation in 101 patients with liver insufficiency.
    Koivusalo AM; Vakkuri A; Höckerstedt K; Isoniemi H
    Transplant Proc; 2005 Oct; 37(8):3315-7. PubMed ID: 16298584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up.
    Donati G; La Manna G; Cianciolo G; Grandinetti V; Carretta E; Cappuccilli M; Panicali L; Iorio M; Piscaglia F; Bolondi L; Colì L; Stefoni S
    Artif Organs; 2014 Feb; 38(2):125-34. PubMed ID: 23834711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One hundred sixteen cases of acute liver failure treated with MARS.
    Novelli G; Rossi M; Pretagostini M; Pugliese F; Ruberto F; Novelli L; Nudo F; Bussotti A; Corradini S; Martelli S; Berloco PB
    Transplant Proc; 2005; 37(6):2557-9. PubMed ID: 16182742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.
    Mitzner SR; Stange J; Klammt S; Risler T; Erley CM; Bader BD; Berger ED; Lauchart W; Peszynski P; Freytag J; Hickstein H; Loock J; Löhr JM; Liebe S; Emmrich J; Korten G; Schmidt R
    Liver Transpl; 2000 May; 6(3):277-86. PubMed ID: 10827226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.